J.M. Altenburger - Concepedia

Author

J.M. Altenburger

Sanofi (France)

Also Known As

J. M. ALTENBURGER, J.M. Altenburger, J.‐M. ALTENBURGER, Jean-Michel Altenburger, Jean‐Michel Altenburger

Publications

445

Citations

H-Index

Concepts

All Affiliations

Sanofi (France)Centre National de la Recherche Scientifique

About

J.M. Altenburger is an author at Sanofi (France) specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	243
2	Natural Sciences	4	4	170
3	Biochemistry	4	4	170
4	Engineering	1	1	43
5	Biomolecular Engineering	1	1	43

J.M. Altenburger

Publications

436

Citations

H-Index

Page 1

	Year	Citations
SSR182289A, a selective and potent orally active thrombin inhibitor J.M. Altenburger, Gilbert Lassalle, Mostapha Matrougui, Bioorganic & Medicinal Chemistry ThrombosisBlood PlateletMedicineHematologyAnticoagulant	2004	132
Difluoromethyleneketone retroamide, a versatile concept of inactivation of proteolytic enzymes Daniel Schirlin, S. Baltzer, J.M. Altenburger, Tetrahedron Bioorganic ChemistryCellular EnzymologyBiochemistryNatural SciencesBiocatalysis	1996	59
General synthesis of polyfunctionalized fluoromethyleneketone retroamides as potential inhibitors of thrombin J.M. Altenburger, Daniel Schirlin Tetrahedron Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineFluorous Synthesis	1991	50
Useful hydroxylamine derivatives for the synthesis of hydroxamic acids. J.M. Altenburger, Charles Mioskowski, Hugues d'Orchymont, Tetrahedron Letters EngineeringUseful Hydroxylamine DerivativesOrganic ChemistryNatural Product SynthesisChemical Derivative	1992	43
Short and unexpectedly potent difluorostatone type inhibitors of HIV-1 protease Daniel Schirlin, S. Baltzer, V. Van Dorsselaer, Bioorganic & Medicinal Chemistry Letters Hiv-1 ProteaseBiochemistryMedicineNatural SciencesAntiviral Drug Development	1993	36
5-Chlorothiophene-2-carboxylic Acid [(<i>S</i>)-2-[2-Methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a Selective and Potent Orally Active Dual Thrombin and Factor Xa Inhibitor Jérôme Meneyrol, Markus Follmann, Gilbert Lassalle, Journal of Medicinal Chemistry Compound 14PharmacotherapyPharmaceutical ChemistryRat ModelMolecular Pharmacology	2013	25
A convenient synthesis of α',β-diamino-α,α-difluoroketones, new dipeptide isosteres Daniel Schirlin, S. Baltzer, J.M. Altenburger Tetrahedron Letters Combinatorial ChemistryOrganic ChemistryPeptide ScienceNew Dipeptide IsosteresChemistry	1988	25
SSR182289A, a Novel, Orally Active Thrombin Inhibitor: In Vitro Profile and ex Vivo Anticoagulant Activity Christopher N. Berry, Gilbert Lassalle, Catherine Lunven, Journal of Pharmacology and Experimental Therapeutics	2002	22
Synthesis and antiviral activity of rigid acyclonucleotide analogs Patrick Casara, J.M. Altenburger, Debra L. Taylor, Bioorganic & Medicinal Chemistry Letters Antiviral Drug DevelopmentMolecular BiologyAntiviral DrugRigid Acyclonucleotide AnalogsAntiviral Compound	1995	17
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities Marie‐Laure Ozoux, Véronique Briand, Michel Pelat, Journal of Pharmacology and Experimental Therapeutics	2020	15

Page 1